健脾化痰消瘿汤对肺癌免疫治疗致甲状腺功能 异常患者自身免疫、吞咽功能及 血 清 MIP-1α、 sIL-2R 和 S-TK1 的影响.

OBJECTIVE: To probe into the effects of Jianpi Huatan Xiaoying decoction on autoimmunity, swallowing function and serum Macrophage Inflammatory protein 1α (MIP-1α), soluble interleukin receptor (sIL-2R) and thymidine kinase 1 ( S-TK1) in patients with thyroid dysfunction induced by immunotherapy of lung cancer. METHODS: Totally 88 patients with lung cancer admitted into the Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine from Feb. 2020 to Feb. 2022 were extracted to be divided into the control group and the study group via the random number table method. Forty-four patients in the control group were treated with PD-1/ PD-L1 immune checkpoint inhibitor combined with conventional chemotherapy, while 44 patients in the study group received Jianpi Huatan Xiaoying decoction on the basis of the control group. Before and after treatment, immunoglobulin M (IgM), T lymphocyte subsets CD4 +, CD8 +, MIP-1α, SIL-2R, free thyroxin (FT4), thyroid stimulating hormone (TSH), total triiodothyronine (TT3), S-TK1, anti thyroglobulin antibody (TGAb), and thyroid receptor antibody (TRAb) levels were measured. Wata drinking water test was used to determine the swallowing function of patients. The patients were evaluated with the EORTC QLQ-C30. Adverse drug reactions of two groups were compared. RESULTS: After treatment, the levels of IgM and CD4 + in the study group were significantly higher than those in the control group, the levels of CD8 + were significantly lower than those in the control group, the levels of TT3 were significantly higher than those in the control group, the levels of TSH, TGAb and TRAb were significantly lower than those in the control group, the levels of MIP-1α, sIL-2R and S-TK1 were significantly lower than those in the control group, and the scores of swallowing function were significantly lower than those in the control group, the EORTC QLQ-C30 score was significantly higher than that of the control group, with statistically significant differences (P<0. 05). The incidence of adverse drug reactions in the study group was 6. 82% (3 / 44), significantly lower than 29. 55% (13 / 44) in the control group, the difference was statistically significant (P<0. 05). CONCLUSIONS: Jianpi Huatan Xiaoying decoction in the treatment of patients with thyroid dysfunction induced by immunotherapy of lung cancer can reduce the immune function injury of patients, improve the abnormal thyroid function, improve the levels of autoimmune antibodies, decrease the reduced swallowing function of patients, improve the quality of life, and reduce adverse drug reactions. [ABSTRACT FROM AUTHOR]